CSIMarket



Tabula Rasa Healthcare inc.  (TRHC)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

TRHC's Capital Expenditures Growth by Quarter and Year

Tabula Rasa Healthcare's Capital Expenditures results by quarter and year




TRHC Capital Expenditures (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 10.93 5.66 6.47
III Quarter September - 9.28 5.93 6.56
II Quarter June 9.38 8.60 5.35 6.48
I Quarter March 8.97 6.39 4.99 3.65
FY   18.35 35.20 21.93 23.16



TRHC Capital Expenditures second quarter 2022 Y/Y Growth Comment
Tabula Rasa Healthcare inc. reported Capital Expenditures growth of 9.01% year on year in the second quarter 2022, to $ 9.38 millions, this is lower than Tabula Rasa Healthcare Inc.'s recent average Capital Expenditures increase of 10.17%.

Looking into second quarter 2022 results within Healthcare Facilities industry 29 other companies have achieved higher Capital Expenditures growth. While Tabula Rasa Healthcare Inc.' s Capital Expenditures increase of 9.01% ranks overall at the positon no. 1795 in the second quarter 2022.




TRHC Capital Expenditures ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 93.11 % -12.52 % 84.86 %
III Quarter September - 56.49 % -9.6 % 181.55 %
II Quarter June 9.01 % 60.75 % -17.44 % 152.14 %
I Quarter March 40.38 % 28.06 % 36.71 % 67.43 %
FY   - 60.51 % -5.31 % 118.9 %

Financial Statements
Tabula Rasa Healthcare's second quarter 2022 Capital Expenditures $ 9.38 millions TRHC's Income Statement
Tabula Rasa Healthcare's second quarter 2021 Capital Expenditures $ 8.60 millions Quarterly TRHC's Income Statement
New: More TRHC's historic Capital Expenditures Growth >>


TRHC Capital Expenditures (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 17.78 % -4.55 % -1.37 %
III Quarter September - 7.91 % 10.84 % 1.23 %
II Quarter June 4.52 % 34.59 % 7.21 % 77.53 %
I Quarter March -17.93 % 12.9 % -22.87 % 4.29 %
FY (Year on Year)   - 60.51 % -5.31 % 118.9 %




Capital Expenditures second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #30
Healthcare Sector #332
Overall #1795

Capital Expenditures Y/Y Growth Statistics
High Average Low
32.47 % 10.17 % -4.58 %
(Jun 30 2019)   (Jun 30 2020)
Capital Expenditures second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #30
Healthcare Sector #332
Overall #1795
Capital Expenditures Y/Y Growth Statistics
High Average Low
32.47 % 10.17 % -4.58 %
(Jun 30 2019)   (Jun 30 2020)

Capital Expenditures by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Tabula Rasa Healthcare's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
77.5 % 9.12 % -60.25 %
(Jun 30 2019)  


TRHC's II. Quarter Q/Q Capital Expenditures Comment
Tabula Rasa Healthcare inc. achieved in the II. Quarter 2022 below company average Capital Expenditures growth of 4.52% quarter on quarter, to $ 9.38 millions.

Within Healthcare Facilities industry 26 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Tabula Rasa Healthcare's Capital Expenditures growth quarter on quarter, overall rank is 1843.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #27
Healthcare Sector #378
Overall #1843
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #27
Healthcare Sector #378
Overall #1843
Capital Expenditures Q/Q Growth Statistics
High Average Low
77.5 % 9.12 % -60.25 %
(Jun 30 2019)  


TRHC's II. Quarter Q/Q Capital Expenditures Comment
Tabula Rasa Healthcare inc. achieved in the II. Quarter 2022 below company average Capital Expenditures growth of 4.52% quarter on quarter, to $ 9.38 millions.

Within Healthcare Facilities industry 26 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Tabula Rasa Healthcare's Capital Expenditures growth quarter on quarter, overall rank is 1843.


Tabula Rasa Healthcare's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
Cumulative Capital Expenditures 12 Months Ending $ 38.55 $ 37.78 $ 35.19 $ 29.92 $ 26.56
Y / Y Capital Expenditures Growth (TTM) 45.14 % 61.98 % 60.51 % 31.53 % 13.6 %
Year on Year Capital Expenditures Growth Overall Ranking # 1029 # 827 # 326 # 915 # 1036
Seqeuential Capital Expenditures Change (TTM) 2.06 % 7.33 % 17.64 % 12.62 % 13.9 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1795 # 1195 # 395 # 1136 # 989




Cumulative Capital Expenditures growth Comment
With the quarterly Capital Expenditures reported in the Jun 30 2022 period, Tabula Rasa Healthcare's cumulative twelve months Capital Expenditures were $ 39 millions, company would post below average annual Capital Expenditures growth of 13.9% year on year, if the fiscal year would end at Jun 30 2022.
A slow-down in the Tabula Rasa Healthcare's Capital Expenditures growth from the 8.97% growth in Mar 31 2022.

In the Healthcare sector 186 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 827 to 1029.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
32.47 %
10.17 %
-4.58 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 30
Healthcare Sector # 187
Overall # 1029

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
128.04 %
54.94 %
-5.34 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 332
S&P 500 # 1795
Cumulative Capital Expenditures growth Comment
With the quarterly Capital Expenditures reported in the Jun 30 2022 period, Tabula Rasa Healthcare's cumulative twelve months Capital Expenditures were $ 39 millions, company would post below average annual Capital Expenditures growth of -5.34% year on year, if the fiscal year would end at Jun 30 2022.
A slow-down in the Tabula Rasa Healthcare's Capital Expenditures growth from the 8.97% growth in Mar 31 2022.

In the Healthcare sector 186 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 827 to 1029.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
32.47 %
10.17 %
-4.58 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 30
Healthcare Sector # 187
Overall # 1029

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
128.04 %
54.94 %
-5.34 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 332
S&P 500 # 1795




Other Capital Expenditures Growth
Healthcare Facilities Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
TRHC's Capital Expenditures Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for TRHC's Competitors
Capital Expenditures Growth for Tabula Rasa Healthcare's Suppliers
Capital Expenditures Growth for TRHC's Customers

You may also want to know
TRHC's Annual Growth Rates TRHC's Profitability Ratios TRHC's Asset Turnover Ratio TRHC's Dividend Growth
TRHC's Roe TRHC's Valuation Ratios TRHC's Financial Strength Ratios TRHC's Dividend Payout Ratio
TRHC's Roa TRHC's Inventory Turnover Ratio TRHC's Growth Rates TRHC's Dividend Comparisons



Companies with similar Capital Expenditures growth for the quarter ending Jun 30 2022 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Jun 30 2022
Ptc Therapeutics inc.15.19%$ 15.186 millions
Verve Therapeutics Inc.14.44%$ 14.436 millions
Progyny Inc.13.95%$ 13.953 millions
Navidea Biopharmaceuticals Inc.13.50%$ 13.503 millions
Tempest Therapeutics Inc.13.10%$ 13.095 millions
Teva Pharmaceutical Industries Limited12.39%$ 12.389 millions
Iteos Therapeutics Inc.12.23%$ 12.227 millions
Teleflex Incorporated11.41%$ 11.413 millions
Pacira Biosciences inc.11.22%$ 11.222 millions
Keros Therapeutics Inc.11.18%$ 11.176 millions
Iqvia Holdings Inc.11.03%$ 11.034 millions
Fulgent Genetics Inc.11.01%$ 11.005 millions
Msa Safety Inc10.49%$ 10.489 millions
Exact Sciences Corporation9.83%$ 9.832 millions
Celsion Corporation9.69%$ 9.690 millions
Tabula Rasa Healthcare inc.9.06%$ 9.062 millions
Seaspine Holdings Corporation8.81%$ 8.810 millions
Tandem Diabetes Care Inc.8.71%$ 8.712 millions
Baxter International Inc.8.23%$ 8.228 millions
Nrx Pharmaceuticals Inc.7.80%$ 7.797 millions
Immucell Corp7.27%$ 7.273 millions
Vertex Pharmaceuticals Inc6.95%$ 6.949 millions
Biomarin Pharmaceutical Inc6.79%$ 6.792 millions
Vaxart Inc.5.58%$ 5.583 millions
Inozyme Pharma Inc.5.26%$ 5.263 millions
Merit Medical Systems Inc5.17%$ 5.173 millions
Bridgebio Pharma Inc.5.03%$ 5.028 millions
Resmed Inc.4.93%$ 4.933 millions
Utah Medical Products Inc4.72%$ 4.717 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AMIH's Profile

Stock Price

AMIH's Financials

Business Description

Fundamentals

Charts & Quotes

AMIH's News

Suppliers

AMIH's Competitors

Customers & Markets

Economic Indicators

AMIH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071